Insmed Inc’s filing revealed that its DIRECTOR MELVIN SHAROKY acquired Company’s shares for reported $4.1 million on Dec 05 ’25. In the deal valued at $205.00 per share,20,000 shares were bought.
Then, Lewis William sold 10,699 shares, generating $2,199,915 in total proceeds. Upon selling the shares at $205.62, the Chair and CEO now owns 303,911 shares.
Before that, William Lewis bought 10,699 shares. Insmed Inc shares valued at $2,199,583 were divested by the Officer at a price of $205.59 per share.
Rothschild & Co Redburn initiated its Insmed Inc [INSM] rating to a Buy in a research note published on December 04, 2025; the price target was $263. Wells Fargo began covering INSM with “an Overweight” recommendation on October 20, 2025. William Blair started covering the stock on August 20, 2025. It rated INSM as “an Outperform”.
Price Performance Review of INSM
On Friday, Insmed Inc [NASDAQ:INSM] saw its stock fall -0.51% to $204.0. Over the last five days, the stock has lost -1.81%. Insmed Inc shares have risen nearly 181.65% since the year began. Nevertheless, the stocks have risen 195.48% over the past one year. While a 52-week high of $212.75 was reached on 12/02/25, a 52-week low of $60.40 was recorded on 04/09/25.
Levels Of Support And Resistance For INSM Stock
The 24-hour chart illustrates a support level at 202.58, which if violated will result in even more drops to 201.16. On the upside, there is a resistance level at 205.99. A further resistance level may holdings at 207.97.
How much short interest is there in Insmed Inc?
A steep rise in short interest was recorded in Insmed Inc stocks on 2025-11-14, dropping by -0.55 million shares to a total of 8.93 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 9.48 million shares. There was a decline of -6.21%, which implies that there is a negative sentiment for the stock.
